Biotechnology company Bharat Biotech has introduced world's first clinically proven typhoid conjugate vaccine, Typbar-TCV, to protect infants aged six months and more and adults from typhoid fever caused by Salmonella typhi. Commercial ...
Tags: Bharat Biotech, Vaccine
The US Food and Drug Administration (FDA) has approved GlaxoSmithKline's Flulaval Quadrivalent (Influenza Virus Vaccine) for the active immunization of people three years of age and more to help prevent disease caused by seasonal influenza ...
Tags: Flulaval Quadrivalent
The Australian Therapeutic Goods Administration (TGA) has granted approval for Novartis' multi-component Meningococcal B (MenB) vaccine, Bexsero, for use against a dangerous form of bacterial meningitis, MenB disease. The approval will ...
Tags: Menb Disease, Medicine
DeltaTRAK has launched a certified reusable data logger with glycol bottle, the FlashLink USB Data Logger with Glycol Bottle, compatible with CDC guidelines. Designed for monitoring temperatures of vaccines inside refrigerators or ...
Tags: Deltatrak, USB Data Logger
Regen BioPharma, a wholly owned subsidiary of Bio-Matrix Scientific, has signed a licensing deal with Benitec Biopharma for ddRNAi gene silencing technology to develop vaccines. Regen will apply ddRNAi to silence indoleamine 2,3 -- ...
Tags: Regen BioPharma, Medicine
Pharmaceutical and healthcare company GlaxoSmithKline (GSK) will roll out two-dimensional (2D) barcodes on the inner containers as well as outer boxes for most of its US vaccines. According to the company, a 2D barcode is a small square ...
Tags: GlaxoSmithKline, 2D Barcodes
The US Food and Drug Administration (FDA) has approved the supply of GlaxoSmithKline's four-strain (quadrivalent) influenza vaccine, Fluarix Quadrivalent, to CDC distribution centers and healthcare providers in the US. Fluarix ...
The US Food and Drug Administration (FDA) has expanded age indication for Novartis' Menveo (Meningococcal [Groups A, C, Y and W-135] Oligosaccharide Diphtheria CRM197 Conjugate Vaccine) to include infants and toddlers aged two months and ...
Pfizer is planning for internal classification of its commercial operations into three business segments, which will include developed and emerging markets, in an effort to deliver value to consumers and patients. The three business ...
Tags: Pfizer, Commercial Businesses
GlaxoSmithKline (GSK) is mulling to establish a joint venture (JV) with a Chinese company as part of its vaccine strategy of teaming up with local partners. The plans come at a time when the company is facing corruption and tax laws ...
Tags: Vaccine Research, GSK
Japanese Mitsubishi Tanabe Pharma (MTPC) has agreed to acquire Medicago, a biopharma company that develops vaccines, in a deal valued at nearly $357m. Based on the terms of the definitive agreement, the acquirer will purchase all of the ...
Tags: Mitsubishi, Pharma, Medicago
Pfizer has obtained European approval for the expanded use of Prevenar 13 (pneumococcal polysaccharide conjugate vaccine [13-valent, adsorbed]), in adults between 18 to 49 years of age for the prevention of invasive pneumococcal disease. ...
Tags: Pneumococcal Vaccine, Medicine
The US FDA has cleared Sanofi Pasteur's supplemental biologics license application (sBLA) licensing four-strain influenza vaccine, Fluzone Quadrivalent, for broad age range of children and adults. As the first and only four-strain ...
Tags: Influenza Vaccine, Medicine
It was a day of revelation as 2 million people in 436 cities rallied against Monsanto and declared genetically modified crops the beast of the age. Inflated numbers, but regardless, there were a legion of protestors that gathered worldwide ...
Tags: Monsanto, Agriculture&Food
GlaxoSmithKline (GSK) has acquired a Switzerland-based vaccines company, Okairos, for €250m in cash to boost its existing vaccine platform technology expertise and to continue developing the next generation of vaccines. Under the ...
Tags: Glaxosmithkline, Vaccines Business